Deprescribing tool development in India: a modified Delphi study

Quick takeaway

This Delphi study develops an India-specific deprescribing tool that accounts for local prescribing realities such as fixed-dose combinations and herb-drug interactions.

Why this matters

Important for medication safety because it moves deprescribing guidance closer to Indian practice patterns.

Key caution

The tool still needs pragmatic trials or implementation studies to show that it improves clinical outcomes.